ESC 365 - Welcome and introduction.

ESC Premium Access

Welcome and introduction.

Session: Towards a new standard of care in coronary and peripheral artery disease: from trial results to guidelines and beyond

Topic: Treatment

Speaker: Professor R. Welsh (Edmonton, CA)

Sponsored by Bayer AG

Event: ESC Congress 2020

Congress Presentation

About the speaker

Professor Robert Welsh

Mazankowski Alberta Heart Institute, Edmonton (Canada)

15 presentations

0 follower

5 more presentations in this session

Protecting the patient that needs more: moving from ‘stable coronary artery disease’ to ‘chronic coronary syndromes’.

Speaker: Professor J. Steffel (Zurich, CH)

How can we protect patients long-term after a percutaneous coronary intervention (PCI)?

Speaker: Professor R. Welsh (Edmonton, CA)

Protecting the patient undergoing lower extremity revascularization for symptomatic PAD.

Speaker: Professor M. Bonaca (Aurora, US)

Optimizing protection for patients with symptomatic chronic peripheral artery disease.

Speaker: Professor M. Brodmann (Graz, AT)

Live Questions and Answers and closing.

Access the full session

Towards a new standard of care in coronary and peripheral artery disease: from trial results to guidelines and beyond

Speakers: Professor R. Welsh, Professor J. Steffel, Professor R. Welsh, Professor M. Bonaca, Professor M. Brodmann

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

Related content

Open Access

Integrating EPA based therapy in the management of residual risk.

29 August 2021

Open Access

How the new guidance will impact the treatment of elderly atrial fibrillation patients in clinical practice.

28 August 2021

Open Access

What is new in the 2021 EHRA Practical Guide on the use of NOACs in patients with atrial fibrillation.

28 August 2021

ESC 365 is supported by